QA: Aclaris Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001557746_2020_Aclaris_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001557746, Aclaris Therapeutics Inc

  xvar xval
0 AssetsCurrent 83,803,000
1 IntangibleAssetsNetIncludingGoodwill 7,199,000
2 PropertyPlantAndEquipmentNet 2,470,000
3 remainder_Assets 4,825,000
4 LiabilitiesCurrent 22,432,000
5 LiabilitiesNoncurrent 3,736,000
6 remainder_Liabilities 2,217,000
7 CostOfGoodsAndServicesSold 4,648,486
8 SellingGeneralAndAdministrativeExpense 26,967,835
9 ResearchAndDevelopmentExpense 66,799,294
10 remainder_Expenses 31,103,062
11 remainder_Revenues 6,171,152
12 remainder_NetIncome 1,696,650
13 remainder_ComprehensiveNetIncome 14,879
  yvar yval
0 Assets 98,297,000
1 Liabilities 28,385,000
2 Expenses 129,518,677
3 Revenues 6,171,152
4 StockholdersEquity 69,912,000
5 NetIncome -121,650,875
6 ComprehensiveNetIncome -121,643,436
7 BaseVar 132,041,679
8 EconomicCapitalRatiobeforeLimitedLiability 0.486
9 EconomicCapitalRatio 1.87

Edgar->Model Mapping

Feature Distribution

Change over Time